An integrated MELD model including serum
โ
Angelo Luca; Berhard Angermayr; Guido Bertolini; Franz Koenig; Giovanni Vizzini;
๐
Article
๐
2007
๐
John Wiley and Sons
๐
English
โ 153 KB
๐ 1 views
The Model for End-Stage Liver Disease (MELD) is widely used to predict the short-term mortality in patients with cirrhosis, but potential limitations of this score have been reported. The aim of this study was to improve the score's prognostic accuracy by assessing new objective variables. Data of 3